Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Teva Pharma appoints Novartis, Biogen vet as new president and CEO – PharmaLive
64 Teva Pharmaceutical Industries Images, Stock Photos & Vectors | Shutterstock
Teva, one of the biggest generic makers, joins the the brand-name club
Articles with Teva Pharmaceuticals
Teva Pharmaceuticals and IBM Partner to Build Global e-Health Solutions on the IBM Watson Health Cloud
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Factory Shutdown in Irvine Affects 25 Drugs: Report - Orange County Business Journal
Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States | Business Wire
CSRWire - Teva Pharmaceutical
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Teva Pharmaceuticals Acquisition – PL Developments
Teva Pharmaceuticals | The National Association of Free & Charitable Clinics
Teva reaches tentative $4.25 billion settlement over opioids | The Seattle Times
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Brand New: New Logo for Teva Pharmaceutical
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva halts production at sterile injectables plant to address FDA concerns | Fierce Pharma
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Boston Jury Awards Teva Pharmaceuticals $176.5M for Eli Lilly's Migraine Medication Patent Infringement | Law.com
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva announces $519 million FCPA settlement | The FCPA Blog
Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Teva extends global rebrand with tailored marketing messages for caregivers | Fierce Pharma
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
